UNSPSC 51172336: Levoleucovorin

Levoleucovorin injection is a folate indicated for rescue after high-dose methotrexate therapy in osteosarcoma and diminishing the toxicity and counteracting the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists.

UNSPSC 51172336 Levoleucovorin, a Commodity code, does not align with recent state and local procurement activity in the available record. The three most recent opportunities posted under or near this code involve drug testing services (Collin County specimen collection and confirmation testing), direct-to-manufacturer pharmaceutical distribution programs (Texas HHS Commission RFI), and cooperative purchasing of generic multi-source pharmaceuticals and OTC products (Minnesota MMCAP). None of these solicitations explicitly identify levoleucovorin—a chemotherapy adjuvant—as a line item or required commodity. The mismatch suggests that this code sees little focused procurement activity among state and local agencies at present, or that recent opportunities have been tagged imprecisely.

The available opportunities do reflect broader state and local pharmaceutical procurement activity across different channels and jurisdictions. Collin County (Texas) issued an RFP for offender drug testing services with a response deadline of July 23, 2026 and an estimated value of $600,000 over two years plus optional renewals. Texas HHS Commission posted an RFI on direct-to-manufacturer prescription programs in April 2026 to gather market intelligence for future formal solicitation design. Minnesota MMCAP, a multistate cooperative purchasing vehicle administered by the Minnesota Department of Administration, sought generic pharmaceutical and OTC product manufacturers with proposals due March 26, 2026, for a contract term beginning July 1, 2026 and extending through June 30, 2028 with optional extensions. These opportunities span county supervision agencies, state health commissions, and cooperative purchasing alliances but do not establish levoleucovorin as a current procurement focus. Without evidence of active demand under this specific commodity code, the opportunity pipeline appears limited.